Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bargagli, R. Cianti, N. Nikiforakis, B. Magi, M. G. Perari, L. Bini, P. Rottoli (Siena, Italy). The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH). Eur Respir J 2007; 30: Suppl. 51, 1572

Member's Comments

No comment yet.

Related content which might interest you: The anlysis of trace elements in BAL of patients with diffuse lung diseases and Langherans cell histiocytosis Source: Eur Respir J 2007; 30: Suppl. 51, 587s Year: 2007 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Pneumothorax in patients with Langerhans cell histiocytosis Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Adult pulmonary Langerhans' cell histiocytosis Source: Eur Respir J 2006; 27: 1272-1285 Year: 2006 Genetic landscape of adult Langerhans cell histiocytosis with lung involvement Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019 Year: 2020 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Protein analysis of bronchoalveolar lavage in pulmonary Langerhans-cell histiocytosis by a proteomic approach Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Genetic landscape of pulmonary langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Pulmonary langerhans¢ cell histiocytosis (LCH) - a retrospective review of 17 patients Source: Eur Respir J 2003; 22: Suppl. 45, 43s Year: 2003 Proteomic analysis of antioxidant proteins in bronchoalveolar lavage of patients with pulmonary Langerhans-cell histiocytosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Pulmonary Langerhans cell histiocytosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019